Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03632044 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Trigeminal Nerve Blockade
A Phase 4 study of Cleft Palate and Birth Defect, sponsored by University of Florida.
- Active
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03632044: Active Phase 4 study of Cleft Palate and Birth Defect, sponsored by University of Florida.
NCT03632044 is a Phase 4 study of Cleft Palate and Birth Defect that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 40 participants, below the 670-participant average among 9 other Cleft Palate trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03632044, a Phase 4 study of Cleft Palate and Birth Defect, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Cleft palate repair requires high doses of opioids for pain control postop. An alternative approach is placement of nerve blocks in the pterygopalatine fossa bilaterally, blocking the maxillary nerve \& covering the entire midface. Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve may provide effective analgesia for cleft lip repair, improving time to oral intake, pain control and time to hospital discharge.
Primary Outcome
Application of bilateral suprazygomatic maxillary nerve blockade of the infraorbital nerve to provide effective analgesia for cleft lip repair, improving time to oral intake after surgery.
Conditions Studied
Interventions
- DRUG Ropivacaine
- OTHER Sham Comparator
Study Locations (1)
Florida
- UF Health - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-11-20 |
| Est. Completion | 2027-10-30 |
| Phase | Phase 4 |
What the registry record for NCT03632044 still lists
NCT03632044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 670-participant average among 9 other Cleft Palate trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Cleft Palate appearing as the primary indexed condition, and to 2 interventions - of which Ropivacaine is the first listed.
NCT03632044 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03632044 about?
NCT03632044 is a clinical study titled "Evaluation of Trigeminal Nerve Blockade". Cleft palate repair requires high doses of opioids for pain control postop. An alternative approach is placement of nerve blocks in the pterygopalatine fossa bilaterally, blocking the maxillary nerve \& covering the entire midface. Application of bilateral suprazygomatic maxillary nerve blockade of ...
What is the current status of trial NCT03632044?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2018-11-20. Estimated completion is 2027-10-30.
What conditions does trial NCT03632044 study?
This clinical trial studies the following conditions: Cleft Palate, Birth Defect, Mouth Abnormalities.
What interventions are being tested in trial NCT03632044?
The interventions under investigation include: Ropivacaine (DRUG), Sham Comparator (OTHER).
Who is sponsoring clinical trial NCT03632044?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03632044 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cleft Palate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03632044's enrollment target sits among peer trials
40 9th of 9 higher than 1 of 9 other Cleft Palate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cleft Palate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Targeting Surgeons' Decision-Making for Cleft Lip Surgery
ACTIVE NOT RECRUITING · NA
-
Retrospective Study on the Outcome of Cleft Palate Repair: Comparing US Surgical and Ethicon Suture Materials
COMPLETED
-
Efficacy of Oral Versus Intravenous Acetaminophen for Primary Pediatric Cleft Palate Repair
COMPLETED · NA
-
Sleep and Behavior in Children With Cleft Palate
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI